Charles Holley - Amgen Insider

Amgen Inc -- USA Stock  

USD 186.11  0.18  0.10%

Director

Mr. Charles M. Holley, Jr., serves as Director of the Company. Mr. Holley has served as a director of the Company since February 1, 2017. Mr. Holley was first identified to the Governance and Nominating Committee as a potential director candidate by the Companys outside search firm. Mr. Holley is the former Executive Vice President and Chief Financial Officer for WalMart Stores, Inc., or Walmart, where he served from November 2010 to December 2015 and as Executive Vice President between January 1, 2016 and January 31, 2016. Prior to this, Mr. Holley served as Executive Vice President, Finance and Treasurer of Walmart from 2007 to November 2010. From December 2005 through December 2006, he served as Senior Vice President. Prior to that, Mr. Holley was Senior Vice President and Controller from 2003 to 2005. Mr. Holley served various roles in WalMart International from 1994 through 2002. Prior to this, Mr. Holley served in various roles at Tandy Corporationrationration. He spent more than ten years with Ernst Young LLP. Mr. Holley is an Independent Senior Advisor, U.S. CFO Program, Deloitte LLP, a privatelyheld provider of audit, consulting, tax, and advisory services, since July 2016.
Age: 59  Director Since 2017      
805 447-1010  www.amgen.com
Holley serves on the Dean Advisory Board for the McCombs School of Business at the University of Texas at Austin and the University of Texas Presidents' Development Board.

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

William SpenglerEndo International plc
2008
Jill SmithEndo International plc
2012
John StrattonAbbott Laboratories
2017
William YoungVertex Pharmaceuticals Incorpor
2014
Michael HyattEndo International plc
N/A
Glenn TiltonAbbott Laboratories
2007
Daniel StarksAbbott Laboratories
2017
Edward LiddyAbbott Laboratories
2010
Jack GreenbergQuintiles IMS Holdings Inc
2016
Deborah NeffBio Rad Laboratories Inc
2011
Mireille GillingsQuintiles IMS Holdings Inc
2013
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Patrick OSullivanAllergan plc
2013
Shane CookeEndo International plc
2014
Ronald RittenmeyerQuintiles IMS Holdings Inc
2016
James BloemAllergan plc
2013
Christopher BodineAllergan plc
2013
Peter McDonnellAllergan plc
2015
Christopher CoughlinAllergan plc
2016
Christopher GordonQuintiles IMS Holdings Inc
2009
John LeonardQuintiles IMS Holdings Inc
2015

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Price Ceiling Movement Now
   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
Hide  View All  Next  Launch Price Ceiling Movement
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators